COMMUNIQUÉS West-GlobeNewswire

-
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
27/05/2025 -
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
27/05/2025 -
BioXcel Therapeutics Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
27/05/2025 -
Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation
27/05/2025 -
IMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025
27/05/2025 -
BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
27/05/2025 -
Strongline returns to market, signs deal with QLog to ensure leading staff duress offering is available to health systems around the country
27/05/2025 -
Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
27/05/2025 -
Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis
27/05/2025 -
SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System
27/05/2025 -
Iolyx Therapeutics Announces Phase 2 Results for ILYX-002 in Autoimmune Dry Eye Disease
27/05/2025 -
Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
27/05/2025 -
Court Denies Renovaro Motion for an Expedited Trial in July
27/05/2025 -
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting
27/05/2025 -
Leo International leaps from Lion City to Frankfurt with AI precision health listing
27/05/2025 -
AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders
27/05/2025 -
NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
27/05/2025 -
Forte Medical Revolutionises Women’s Routine Health with Peezy Midstream
27/05/2025 -
Altamira Therapeutics Announces Collaboration on Circular RNA Delivery
27/05/2025
Pages